← Back to Clinical Trials
Recruiting NCT06395935

NCT06395935 Wecare Study in Gastric Cancer Survivors

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06395935
Status Recruiting
Phase
Sponsor Gyeongsang National University Hospital
Condition Gastric Cancer
Study Type INTERVENTIONAL
Enrollment 88 participants
Start Date 2024-04-01
Primary Completion 2025-11-30

Trial Parameters

Condition Gastric Cancer
Sponsor Gyeongsang National University Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 88
Sex ALL
Min Age 19 Years
Max Age 75 Years
Start Date 2024-04-01
Completion 2025-11-30
Interventions
Wecare (website)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The KOrean QUality of life in Stomach cancer patients Study group (KOQUSS) made a method (KOQUSS-40) for assessing appropriately the quality of life of gastric cancer patients who have undergone gastrectomy, and developed a digital platform (Wecare) based on KOQUSS-40. In this study, we propose a randomized controlled trial to compare quality of life after gastrectomy in patients with and without smartphone app support.

Eligibility Criteria

Inclusion Criteria: * Adult patient (19-75 years) who underwent radical gastrectomy Exclusion Criteria: * Patients who were unable to undergo regular follow-up, lacked communication, or were deemed unsuitable to participate in this study by the researcher

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology